<DOC>
	<DOCNO>NCT02044003</DOCNO>
	<brief_summary>The study intend evaluate safety feasibility use Intact Vascular ( Innovasc ) Tack-It Endovascular Dissection Repair System ( Tack Intravascular Staple System ) patient vascular flap infrainguinal due post-angioplasty dissection .</brief_summary>
	<brief_title>Safety &amp; Feasibility Study Tack-It Device Vessel Dissection Repair</brief_title>
	<detailed_description>The primary objective study evaluate safety delivery placement Innovasc Tack Intravascular Staple System vascular flap SFA , create percutaneous transluminal balloon angioplasty Safety evaluate 30-day ( hospital discharge date , whichever long ) rate major adverse event define composite endpoint death , device embolization , occurrence surgery related device , device relate occlusion artery , major unplanned amputation ipsilateral low extremity . The secondary objective evaluate feasibility use Innovasc Tack Intravascular Staple System permanently secure vascular flap . Secondary Evaluation Feasibility ( technical success ) Innovasc Tack Intravascular Staple System ( procedure device ) evaluate acutely follow : - Feasibility define ability accurately place Plaque Tacks resolve post-PTA dissection flap prior conclusion procedure , demonstrate angiography - Acute technical success : Acute luminal patency revascularization procedure use standard angiography demonstrate lumen artery location tack implant remain patent conclusion procedure . The additional objective study assess additional parameter follow : - Long term success assess one ( 1 ) month three ( 3 ) month evaluation post-implant stability Plaque Tack relative vascular external landmark 30 day 3 month via standard x-ray . - Patency 30 day 3 month via duplex scan angiography , whichever deem appropriate follow individual patient principal investigator .</detailed_description>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<criteria>Age &gt; 18 &lt; 85 year Patient patient 's legal representative inform nature study , agree participate sign approve consent form . Patient document chronic limb ischemia Rutherford Category 2 , 3 , 4 , 5 . Clinical condition claudication rest pain ischemic ulceration minor gangrene diagnose investigator Reference vessel diameter 2 7mm Target lesion severely calcify At least one patent tibial runoff vessel present . Patient patent iliac femoral artery allow endovascular access site Introducer Sheath Delivery Catheter treat time procedure achieve &lt; 30 % residual stenosis inflow lesion . Ability pas guidewire across atherosclerotic lesion . No evidence aneurysm acute thrombus target vessel . Severe infect gangrene low extremity Planned major amputation Previously implant stent treatment site Patient morbidly obese clinical condition severely inhibit Xray visualization . Patient connective tissue disease ( e.g. , Marfan 's syndrome ) . Inability tolerate antiplatelet agent Patient hypercoagulable Patient allergy vascular contrast premedicated . Patient acute renal failure chronic renal insufficiency failure measure serum creatinine &gt; 2.2 mg/dL . Patient active systemic infection Patient le one year life expectancy . Patient pregnant nursing .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>angioplasty</keyword>
	<keyword>dissection</keyword>
</DOC>